Equifax (NYSE:EFX) Price Target Increased to $320.00 by Analysts at Needham & Company LLC

Equifax (NYSE:EFXGet Free Report) had its target price upped by equities researchers at Needham & Company LLC from $305.00 to $320.00 in a report issued on Friday, Benzinga reports. The firm currently has a “buy” rating on the credit services provider’s stock. Needham & Company LLC’s target price would indicate a potential upside of 22.94% from the stock’s current price.

Several other equities research analysts also recently commented on the stock. The Goldman Sachs Group boosted their target price on shares of Equifax from $246.00 to $277.00 and gave the company a “neutral” rating in a research note on Friday. Robert W. Baird upped their price target on shares of Equifax from $260.00 to $290.00 and gave the stock an “outperform” rating in a research report on Friday. Bank of America upped their price target on shares of Equifax from $255.00 to $286.00 and gave the stock a “buy” rating in a research report on Thursday. Wolfe Research began coverage on shares of Equifax in a research report on Tuesday, July 9th. They set an “outperform” rating and a $275.00 price target on the stock. Finally, Oppenheimer reduced their price target on shares of Equifax from $291.00 to $272.00 and set an “outperform” rating on the stock in a research report on Friday, April 19th. Four investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $281.24.

Read Our Latest Report on EFX

Equifax Stock Down 1.5 %

EFX opened at $260.30 on Friday. Equifax has a fifty-two week low of $159.95 and a fifty-two week high of $276.69. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.79 and a quick ratio of 0.73. The firm’s fifty day moving average price is $242.61 and its two-hundred day moving average price is $246.88. The company has a market capitalization of $32.18 billion, a P/E ratio of 57.97, a P/E/G ratio of 1.88 and a beta of 1.56.

Equifax (NYSE:EFXGet Free Report) last issued its earnings results on Wednesday, July 17th. The credit services provider reported $1.82 EPS for the quarter, beating the consensus estimate of $1.73 by $0.09. Equifax had a net margin of 10.67% and a return on equity of 18.88%. The company had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.42 billion. During the same quarter in the previous year, the company earned $1.71 EPS. The firm’s revenue for the quarter was up 8.6% compared to the same quarter last year. On average, analysts anticipate that Equifax will post 7.38 EPS for the current year.

Insider Activity

In other news, EVP Carla Chaney sold 5,178 shares of the company’s stock in a transaction dated Friday, May 24th. The stock was sold at an average price of $238.63, for a total value of $1,235,626.14. Following the completion of the sale, the executive vice president now directly owns 16,884 shares of the company’s stock, valued at approximately $4,029,028.92. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, EVP Carla Chaney sold 5,178 shares of the business’s stock in a transaction that occurred on Friday, May 24th. The stock was sold at an average price of $238.63, for a total value of $1,235,626.14. Following the completion of the transaction, the executive vice president now directly owns 16,884 shares in the company, valued at approximately $4,029,028.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO John W. Gamble, Jr. sold 3,650 shares of the business’s stock in a transaction that occurred on Thursday, May 30th. The shares were sold at an average price of $229.24, for a total value of $836,726.00. Following the completion of the transaction, the chief financial officer now owns 62,219 shares of the company’s stock, valued at $14,263,083.56. The disclosure for this sale can be found here. Insiders sold a total of 83,635 shares of company stock valued at $18,969,282 in the last ninety days. 1.57% of the stock is owned by insiders.

Hedge Funds Weigh In On Equifax

Institutional investors and hedge funds have recently modified their holdings of the business. Wetzel Investment Advisors Inc. acquired a new position in shares of Equifax in the 4th quarter valued at approximately $25,000. EntryPoint Capital LLC acquired a new position in shares of Equifax in the 1st quarter valued at approximately $30,000. OFI Invest Asset Management acquired a new position in Equifax during the 1st quarter worth approximately $31,000. First Community Trust NA acquired a new position in Equifax during the 2nd quarter worth approximately $33,000. Finally, Blue Trust Inc. boosted its position in Equifax by 271.4% during the 2nd quarter. Blue Trust Inc. now owns 156 shares of the credit services provider’s stock worth $42,000 after acquiring an additional 114 shares during the last quarter. 96.20% of the stock is currently owned by institutional investors and hedge funds.

Equifax Company Profile

(Get Free Report)

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.

See Also

Analyst Recommendations for Equifax (NYSE:EFX)

Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.